The Journal of Infectious Diseases · 1996 · 175 citations · 25 references
Life SciencesImmunologyCellular ImmunologyMucosal ImmunologyOral ImmunologyGastrointestinal ImmunologyMucosal Barrier FunctionMucosal Immune SystemMucosal ImmunityMucosal T CellsMucosal VaccinesCd4 Positive T CellsCd4+ T Helper Cell ResponsesMucosal AntibodiesMucosal ImmunogenicityMucosal T-cell ResponsesT Cell-mediated Mucosal ResponsesTetanus Toxoid VaccineTh2 Immune Response
Escherichia coli labile toxin (LT) was assessed as mucosal immunogen and as adjuvant for tetanus toxoid (TT) in mice. After oral administration of LT, C57BL/6 (H-2b) and BALB/c(H-2d) mice were high mucosal and serum antibody responders, while C3H/HeN (H-2k) mice were low responders. High responders exhibited mainly serum IgG (including IgG1, IgG2a, and IgG2b), as well as IgM and IgA, while mucosal responses were IgA. Analysis of LT-B-specific CD4+ T helper (Th) cells from Peyer's patches (PP) or from spleen revealed a mixed Th1 (interferon-gamma) and Th2 (interleukin-4 and -5) cell pattern. Oral LT given with TT induced TT-specific response patterns identical to LT-B. Analysis of mRNA from TT-specific PP CD4+ Th cells also revealed a mixed Th1- and Th2- type response. Thus, antibody response profiles induced by LT are regulated by both CD4+ Th1 and Th2 cell types.
25
IL-4 is required to generate and sustain in vivo IgE responses.
Fred D. Finkelman, Ildy M. Katona, Joseph F. Urban et al. · The Journal of Immunology · 1988 · 679 citations · Full text
J Xu-Amano, Hiroshi Kiyono, R J Jackson et al. · The Journal of Experimental Medicine · 1993 · 451 citations · Full text